Rare Disease Day is here: Today, we are coming together to #SayScleroderma and shine a light on the 300,000 people in the U.S. living with scleroderma. More than 300 million...
Read More
Check your CONQUEST eligibility, celebrate Raynaud's Awareness Month and Rare Disease Day, and meet newest SRF staff member, Anoushka! Read Now
Read More
Did you know that 300 million people worldwide live with a rare disease? In this video, Elisabeth K., PhD (dx 2021) shares why she believes that funding research on rare...
Read More
Boehringer Ingelheim has announced that its Phase III FIBRONEER-ILD trial examining nerandomilast met its primary endpoint, measuring lung function through forced vital capacity (FVC) at 52 weeks. While nerandomilast remains...
Read More
Rare Disease Day is coming soon—a time to shine a light on the millions of people living with rare diseases, like scleroderma. At the Scleroderma Research Foundation (SRF), we believe...
Read More
February is Raynaud's Awareness Month, and we’re sharing stories that highlight the real impact of Raynaud’s and scleroderma. In this video, Anita reads a heartfelt letter written by her daughter,...
Read More
CONQUEST is proud to be a sponsor of the EUSTAR Course 2025, which took place from February 6-8 in Bordeaux, France. Dr. Gregory Gordon, Chief Medical Officer of the Scleroderma...
Read More
Today, we invite you to join us in defending the foundation of American science. SRF Chairman and scleroderma patient Luke Evnin, PhD, has partnered with Peter Rubin of No Patient...
Read More
“My third-grade teacher called my parents after I almost passed out during recess,” Tomisa S. (dx 1993) recalls of her initial experiences with scleroderma. “Later that day, my mother took...
Read More
